Cargando…
The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study
BACKGROUND: Approximately 30% of dogs with idiopathic epilepsy (IE) are drug‐resistant. Recent studies have suggested cannabidiol (CBD) may be an effective anticonvulsant in dogs with IE. OBJECTIVE: To evaluate the addition of CBD to antiseizure drugs (ASDs) on seizure frequency and to report advers...
Autores principales: | Rozental, Aaron J., Weisbeck, Brooke G., Corsato Alvarenga, Isabella, Gustafson, Daniel L., Kusick, Breonna R., Rao, Sangeeta, Bartner, Lisa R., McGrath, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658598/ https://www.ncbi.nlm.nih.gov/pubmed/37889215 http://dx.doi.org/10.1111/jvim.16912 |
Ejemplares similares
-
Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022) -
Testing for Bartonella ssp. DNA in cerebrospinal fluid of dogs with inflammatory central nervous system disease
por: Bartner, Lisa R., et al.
Publicado: (2018) -
Cannabidiol plasma determination and pharmacokinetics conducted at beginning, middle and end of long-term supplementation of a broad-spectrum hemp oil to healthy adult dogs
por: Corsato Alvarenga, Isabella, et al.
Publicado: (2023) -
Thoracolumbar myelopathies in pug dogs
por: Wachowiak, Ian J., et al.
Publicado: (2023) -
Clinical characterization of epileptic seizures in Pomeranians with idiopathic epilepsy or epilepsy of unknown cause
por: Yu, Yoshihiko, et al.
Publicado: (2022)